SAVIENT PHARMACEUTICALS INC
Healthcare · Medicinal Chemicals & Botanical Products · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY12 | FY11 | FY10 | FY09 | FY08 | |
|---|---|---|---|---|---|
| Revenue | $3.5M | $1.3M | $1.1M | $3.0M | $3.2M |
| Operating income | −$119.1M | −$115.4M | −$56.0M | −$81.2M | −$89.0M |
| Net income | −$34.2M | −$13.5M | −$73.1M | −$90.9M | −$84.2M |
| Total assets | $119.2M | $197.1M | $73.4M | $119.0M | — |
| Total liabilities | — | — | — | — | — |
| Equity | −$138.3M | −$8.4M | $49.3M | $64.2M | $63.4M |
| EPS (diluted) | — | — | — | — | — |
| Shares out. | 71.8M | 70.9M | 70.3M | 66.9M | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2012- Operating margin
- −3370.1%
- Net margin
- −967.7%
- Return on equity
- 24.7%
- Return on assets
- −28.7%
- Return on capital (ROCE)
- −136.0%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $-1.93
- Revenue growth (YoY)
- 174.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2012- Accruals / assets
- 67.6%high accruals
- Piotroski F-Score
- 2/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 2 good- Negative shareholder equity
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- High accruals — earnings-quality risk
- Strong return on equity (>15%)
- Revenue is growing year-over-year
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 17, 2006
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2005
- NT 10-Qmissed a reporting deadline ↗Aug 10, 2005
- NT 10-Kmissed a reporting deadline ↗Mar 16, 2005
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Jaeger Stephen ODirector | Oct 17, 2013 | Sell | 38,061 | $0.05 |
| Yachmetz Philip KOfficer — Co-President and CBO | Oct 15, 2013 | Sell | 20,000 | $0.10 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureMay 30, 2014
- Bankruptcy or receivership · Modified shareholder rights · Regulation FD disclosureMay 20, 2014
- Regulation FD disclosureApr 17, 2014
- Regulation FD disclosureMar 21, 2014
- Regulation FD disclosureMar 18, 2014
- Regulation FD disclosureFeb 21, 2014
- Regulation FD disclosureFeb 11, 2014
- Regulation FD disclosureJan 22, 2014
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- CT ORDERMar 20, 2019
- CT ORDERMay 23, 2017
- 8-KMay 30, 2014
- 8-KFORM 8-KMay 20, 2014
- 8-KFORM 8-KApr 17, 2014
- 8-KMar 21, 2014
- 8-KMar 18, 2014
- 8-KFeb 21, 2014
- SC 13G/ADISCLOSURE DOCUMENTFeb 14, 2014
- SC 13G/AFeb 11, 2014
- SC 13G/AFeb 11, 2014
- 8-KFORM 8-KFeb 11, 2014
- 8-KFORM 8-KJan 22, 2014
- 8-KFORM 8-KJan 10, 2014
- 8-KJan 7, 2014